0001104659-22-006551.txt : 20220121
0001104659-22-006551.hdr.sgml : 20220121
20220121175619
ACCESSION NUMBER: 0001104659-22-006551
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20220119
FILED AS OF DATE: 20220121
DATE AS OF CHANGE: 20220121
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Shetzline Michael
CENTRAL INDEX KEY: 0001808509
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-34620
FILM NUMBER: 22546952
MAIL ADDRESS:
STREET 1: 100 SUMMER STREET, SUITE 2300
CITY: BOSTON
STATE: MA
ZIP: 02110
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: IRONWOOD PHARMACEUTICALS INC
CENTRAL INDEX KEY: 0001446847
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 043404176
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 100 SUMMER STREET, SUITE 2300
CITY: BOSTON
STATE: MA
ZIP: 02110
BUSINESS PHONE: 617-621-7722
MAIL ADDRESS:
STREET 1: 100 SUMMER STREET, SUITE 2300
CITY: BOSTON
STATE: MA
ZIP: 02110
4
1
tm224209-3_4seq1.xml
OWNERSHIP DOCUMENT
X0306
4
2022-01-19
0
0001446847
IRONWOOD PHARMACEUTICALS INC
IRWD
0001808509
Shetzline Michael
C/O IRONWOOD PHARMACEUTICALS, INC.
100 SUMMER STREET, SUITE 2300
BOSTON
MA
02110
0
1
0
0
CMO,SVP,Head-Res&Drug
Class A Common Stock
2022-01-19
4
A
0
29326
0
A
212987
D
Represents shares earned upon satisfaction of certain performance criteria associated with performance-based restricted stock units (PSUs)
granted February 27, 2020 and April 24, 2020. The earned PSUs were certified and vested on January 19, 2022.
/s/ Brian Tessler, Attorney-in-Fact
2022-01-21